SubjectWell provides risk-free patient recruitment for clinical trials. We engage the 96% of Americans who have never participated in clinical trials and we only charge for those who randomize. Unlike traditional approaches to recruiting which are study, site and disease-specific, SubjectWell’s technology continuously recruits nationwide, informing and educating patients about clinical trials in general, at times when they are not thinking about their condition. We then contact and qualify these patients as new trials are added to our marketplace. SubjectWell allows pharmaceutical, biotechnology, and contract research organizations to reach beyond the usual candidate populations in order to deliver results on time.

SubjectWell provides risk-free patient recruitment for clinical trials. We engage the 96% of Americans who have never participated in clinical trials and we only charge for those who randomize. Unlike traditional approaches to recruiting which are study, site and disease-specific, SubjectWell’s technology continuously recruits nationwide, informing and educating patients about clinical trials in general, at times when they are not thinking about their condition. We then contact and qualify these patients as new trials are added to our marketplace. SubjectWell allows pharmaceutical, biotechnology, and contract research organizations to reach beyond the usual candidate populations in order to deliver results on time.

Atropos Health’s ChatRWD blends generative AI based chat interface with our time-honed technologies for rapid real-world evidence

The result is simple Q&A to AI-powered observational studies on the dataset of your choice in minutes. Beating our industry-leading turnaround time with the Green Button Informatics Consult Service.

no similar capability in EHR

Speed, 100% peer-reviewed methodology, generates real world evidence versus summarization of existing literature only